Trials / Conditions / Recurrent Ovarian Carcinosarcoma
Recurrent Ovarian Carcinosarcoma
4 registered clinical trials studyying Recurrent Ovarian Carcinosarcoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without B NCT06393751 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Recruiting | MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer NCT06483048 | Mayo Clinic | Phase 1 |
| Recruiting | Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity NCT05920798 | Mayo Clinic | Phase 1 / Phase 2 |
| Terminated | Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Ca NCT03610490 | M.D. Anderson Cancer Center | Phase 2 |